Johnson & Johnson Family of Companies
NEWS
The COVID-19 pandemic is having a devastating effect on global business and biopharma companies are not excluded.
The FDA recently approved the combination of Imbruvica-Rituximab for treating chronic lymphocytic leukemia. Here’s everything you need to know.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 14, 2020.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 8, 2020.
While the world is working to slow the COVID-19 pandemic by social isolation and quarantine, numerous companies globally are working to develop a vaccine against the virus.
The healthcare giant said it selected a lead vaccine candidate and plans to begin human testing in September, with first batches available under potential emergency use authorization in the first part of 2021.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for March 30, 2020.
The company isn’t out-and-out saying the drug or any combination drugs with darunavir as a formula might not be effective, but they are saying it’s not based on testing at this time.
No financial terms were disclosed.
JOBS
IN THE PRESS
